NCT06658951 2026-03-19
Anti-HER2 CAR-T Cell Injection in Patients With HER2-positive Advanced Malignant Solid Tumors
UTC Therapeutics Inc.
Phase NA Recruiting
Clinical Trials
17 trialsNCT05223608 2026-03-18
ImmuCCo
Centre Oscar Lambret
Phase NA Recruiting
NCT06565260 2026-03-13
Community-Based Exercise and Nutrition Training and Education Program for Cancer Survivors
Roswell Park Cancer Institute
Phase NA Recruiting
NCT06771739 2026-03-13
A Pilot Unrestricted Payment Program for Early-stage Cancer Patients: the PAYMENT Trial
Fred Hutchinson Cancer Center
Phase NA Not yet recruiting
NCT04870788 2026-03-11
Mindfulness-Based Intervention for Latino Cancer Patients and Their Caregivers
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT06367751 2026-03-11
LIQPLAT
University Hospital, Basel, Switzerland
Phase NA Active not recruiting
NCT02701712 2026-03-05
MRgRT
University Health Network, Toronto
Phase NA Active not recruiting
NCT04028570 2026-03-05
SMARTER
University Health Network, Toronto
Phase NA Active not recruiting
NCT05436093 2026-03-04
CLDN18.2 Targeting Nanobody Probe for PET Imaging in Solid Tumors
Peking University Cancer Hospital & Institute
Phase NA Recruiting
NCT07059884 2026-03-04
DEFEND
Alliance for Clinical Trials in Oncology
Phase NA Recruiting
NCT07365007 2026-03-03
A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment
University of Michigan Rogel Cancer Center
Phase NA Recruiting
NCT06295367 2026-03-02
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Eastern Cooperative Oncology Group
Phase NA Recruiting
NCT06945380 2026-02-27
Evaluating a Mobile Health Application Intervention for Caregiver Instruction in Manual Therapy for Chemotherapy-Induced Peripheral Neuropathy
Mayo Clinic
Phase NA Recruiting
NCT07137195 2026-02-27
Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)
Ion Beam Applications
Phase NA Active not recruiting
NCT07438093 2026-02-27
Safety, Tolerability, and Preliminary Efficacy of Peginterferon α-2b in Combination With an Anti-PD-1 Antibody in Patients With Advanced or Metastatic Malignant Solid Tumors
The First Affiliated Hospital of Xiamen University
Phase NA Not yet recruiting
NCT06484595 2026-02-25
GUIDE
Fred Hutchinson Cancer Center
Phase NA Completed
NCT07126496 2026-02-23
A Virtual Community Health Educator for Increasing Clinical Trial Referrals Among Cancer Patients and Their Caregivers
Mayo Clinic
Phase NA Recruiting